IRIS
PASSINO, Claudio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 53.994
EU - Europa 33.019
AS - Asia 26.743
SA - Sud America 5.453
Continente sconosciuto - Info sul continente non disponibili 776
AF - Africa 664
OC - Oceania 142
Totale 120.791
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 50.947
SG - Singapore 9.666
GB - Regno Unito 7.266
RU - Federazione Russa 7.236
IT - Italia 7.098
CN - Cina 6.718
BR - Brasile 4.235
VN - Vietnam 3.667
UA - Ucraina 2.337
DE - Germania 2.314
CA - Canada 2.269
HK - Hong Kong 1.979
BD - Bangladesh 1.756
DK - Danimarca 1.529
FR - Francia 1.130
SE - Svezia 1.011
FI - Finlandia 840
IN - India 574
IE - Irlanda 550
PL - Polonia 538
MX - Messico 481
AR - Argentina 438
NL - Olanda 388
TR - Turchia 329
IL - Israele 279
ID - Indonesia 254
EC - Ecuador 225
IQ - Iraq 216
ZA - Sudafrica 212
PK - Pakistan 210
JP - Giappone 206
ES - Italia 190
CO - Colombia 149
VE - Venezuela 120
AT - Austria 116
AU - Australia 106
EU - Europa 106
UZ - Uzbekistan 100
MA - Marocco 99
SA - Arabia Saudita 91
CL - Cile 88
KR - Corea 79
IR - Iran 72
AE - Emirati Arabi Uniti 71
EG - Egitto 67
MY - Malesia 67
PY - Paraguay 67
KE - Kenya 64
LT - Lituania 62
PH - Filippine 61
PE - Perù 57
CR - Costa Rica 52
TN - Tunisia 52
JM - Giamaica 50
RO - Romania 48
JO - Giordania 46
DZ - Algeria 42
BE - Belgio 41
CH - Svizzera 41
HN - Honduras 38
NP - Nepal 38
PT - Portogallo 36
BO - Bolivia 34
SK - Slovacchia (Repubblica Slovacca) 34
NZ - Nuova Zelanda 33
UY - Uruguay 33
TH - Thailandia 32
AZ - Azerbaigian 31
CZ - Repubblica Ceca 30
ET - Etiopia 30
TT - Trinidad e Tobago 25
GR - Grecia 23
KZ - Kazakistan 23
TW - Taiwan 23
GT - Guatemala 20
NI - Nicaragua 20
DO - Repubblica Dominicana 19
KG - Kirghizistan 18
PS - Palestinian Territory 17
AL - Albania 16
HU - Ungheria 16
OM - Oman 16
PA - Panama 16
QA - Qatar 15
GE - Georgia 13
AM - Armenia 12
LV - Lettonia 12
NO - Norvegia 12
RS - Serbia 12
BB - Barbados 11
BY - Bielorussia 11
MK - Macedonia 11
SN - Senegal 11
SV - El Salvador 11
BG - Bulgaria 10
BH - Bahrain 10
CI - Costa d'Avorio 10
KW - Kuwait 10
LB - Libano 10
MD - Moldavia 10
Totale 119.914
Salva come PNG Salva come JPEG
Città #
Dallas 8.071
Southend 4.837
Singapore 4.830
Ashburn 3.257
San Jose 3.060
Beijing 2.767
Woodbridge 2.677
Chandler 2.320
Ann Arbor 2.295
Houston 2.116
Hong Kong 1.758
Fairfield 1.626
San Mateo 1.470
Moscow 1.304
Falls Church 1.263
Council Bluffs 1.196
Jacksonville 1.113
Seattle 1.098
Los Angeles 1.081
Dearborn 1.020
Milan 1.006
Ho Chi Minh City 999
Cambridge 969
Wilmington 901
Ottawa 865
The Dalles 797
New York 764
Rome 683
Chicago 660
Pisa 649
Hanoi 634
Santa Clara 595
Boardman 548
Hefei 542
Dublin 522
Lauterbourg 513
Stevenage 512
Portsmouth 503
Warsaw 492
Dong Ket 483
São Paulo 458
Buffalo 440
Helsinki 426
Montréal 403
Lawrence 385
Brooklyn 327
Beauharnois 315
London 258
Tel Aviv 251
Munich 247
Orem 244
Salt Lake City 231
Mexico City 214
Montreal 208
Florence 207
Frankfurt am Main 184
San Diego 177
Redwood City 175
Phoenix 167
Tokyo 166
Denver 158
Old Bridge 158
Columbus 157
Toronto 154
Stockholm 152
Atlanta 150
Chennai 150
Istanbul 150
Rio de Janeiro 145
Poplar 141
Figino 140
Amsterdam 134
Da Nang 134
Johannesburg 134
Haiphong 120
Naples 117
Tampa 115
Boston 114
Elk Grove Village 112
Fremont 112
Nuremberg 111
Turin 108
Bologna 97
Manchester 95
Tashkent 90
San Francisco 89
Ankara 78
Shanghai 77
Washington 75
Belo Horizonte 74
Biên Hòa 74
Mumbai 74
Brasília 71
Curitiba 71
Guayaquil 69
Turku 69
Baghdad 68
Dhaka 68
Norwalk 68
Paris 68
Totale 72.620
Salva come PNG Salva come JPEG
Nome #
N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T hold diagnostic value in cardiac amyloidosis 1.707
Value in Healthcare and the Role of the Patient Voice 1.225
Valutazione delle caratteristiche analitiche e dei risultati clinici di un metodo in chemiluminescenza a cattura di microparticelle (CMIA) per il dosaggio della Galectina-3 sulla piattaforma ARCHITECT 700
Left ventricular outflow tract velocity-time integral improves outcome prediction in patients with secondary mitral regurgitation 628
Patient-reported outcome measures for transthyretin cardiac amyloidosis: the ITALY study 624
A cross-correlational analysis between electroencephalographic and end-tidal carbon dioxide signals: Methodological issues in the presence of missing data and real data results 516
E-Health in Tuscany Inner Areas: The PROXIMITY-CARE Approach 510
[ANMCO/ELAS/SIBioC Consensus document: Recommendations for the use of cardiac biomarkers in heart failure patients] 493
Impact of GFR Estimation Formulas on MECKI Score Performance and Prognostic Accuracy in Heart Failure: The MECKI-RENAL Study 487
Autonomic, functional, skeletal muscle, and cardiac abnormalities are associated with increased ergoreflex sensitivity in mitochondrial disease 457
[The use of PROMs (patient-reported outcome measures) and PREMs (patient-reported experience measures) in Cardiology: current state and applications to improve patient care] 453
Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liver disease. 431
b-Gamma-glutamyltransferase activity in human vulnerable carotid plaques. 403
Prognostic Significance of Central Apneas Throughout a 24-Hour Period in Patients With Heart Failure 402
A simple echocardiographic score to rule out cardiac amyloidosis 394
Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liverdisease. 388
Cardiac biomarker testing in the clinical laboratory: Where do we stand? General overview of the methodology with special emphasis on natriuretic peptides 375
Human pathophysiological adaptations to the space environment 373
A simple echocardiographic score to rule out cardiac amyloidosis 371
Grapevine microRNAs in an in vitro model of cell line: new potential insight on their role in the setting of human health. 362
"Targeting and Treating Apneas" in "The Breathless Heart: Apneas in Heart Failure" 362
Functional ancient grain bread rich in iron, zinc, flavonoids and alpha lipoic acid attenuates post-ischemic myocardial remodeling in rats 358
A simple method for measuring baroreflex sensitivity holds prognostic value in heart failure 355
The evolution of TAVI performance overtime: an overview of systematic reviews 352
"To Breathe, or Not to Breathe: That Is the Question" in "The Breathless Heart: Apneas in Heart Failure" 349
La neuropatia diabetica 344
Adaptive servo-ventilation therapy does not favourably alter sympatho-vagal balance in sleeping patients with systolic heart failure and central apnoeas: Preliminary data 343
An open computational toolbox to analyze multi- and single-unit sympathetic nerve activity in microneurography 342
[Central apneas and cardiovascular diseases] 342
A role for gamma-glutamyltransferase in pathogenesis and evolution of cardiovascular diseases. 342
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 341
Comparison between BNP values measured in capillary blood samples with a POCT method and those measured in plasma venous samples with an automated platform 337
Measurement of myocardial amyloid deposition in systemic amyloidosis: insights from cardiovascular magnetic resonance imaging 337
Tuscany Sangiovese Grape juice imparts cardioprotection by regulating gene expression of Cardioprotective C-Type Natriuretic Peptide. 337
Clinical implications of a recent adjustment to the high-sensitivity cardiac troponin T assay: some results. 336
Abnormal hyperventilation in patients with hepatic cirrhosis: Role of enhanced chemosensitivity to carbon dioxide. 335
Peripheral reflex feedbacks in chronic heart failure: Is it time for a direct treatment? 335
The Fondazione Toscana Gabriele Monasterio app: a digital health system to improve wellbeing of inpatients with heart or lung disease 334
Myocardial signal intensity decay after gadolinium injection: a fast and effective method for the diagnosis of cardiac amyloidosis 334
Prediction of the chemoreflex gain by common clinical variables in heart failure 334
N-terminal fragment of B-type natriuretic peptide predicts coexisting subclinical heart and vessel disease 334
Evaluation of analytical performance of a new high-sensitivity immunoassay for cardiac troponin i 333
Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers 333
A longitudinal assessment of chronic care pathways in real-life: self-care and outcomes of chronic heart failure patients in Tuscany 332
Markers of fibrosis, inflammation, and remodeling pathways in heart failure 332
Cocaine assumption and transient myocardial edema in asymptomatic cocaine heavy-users 331
Cardiovascular risk factors and gamma-glutamyltransferase fractions in healthy individuals 329
Treating chemoreflex in heart failure: modulation or demolition? 328
Gender and age normalization and ventilation efficiency during exercise in heart failure with reduced ejection fraction 328
Ancient grain bread rich in iron, zinc, flavonoids and alpha lipoic acid as a novel preoperative functional food for suppressing the progression of cardiovascular remodeling in infarcted male rats 326
Statin intolerance in heterozygous familial hypercolesterolemia with cardiovascular disease: After PCSK-9 antibodies what else? 323
Arrhythmic risk prediction in non-dilated left ventricular cardiomyopathy: The role of overlap with arrhythmogenic cardiomyopathy 322
Natriuretic peptides expression in a murine model of myocardial infarction after Sangiovese grape juice intake. Focus on CNP and ON putative involvement of plant miRNAs in-vitro and in healthy humans 321
Influence of central apneas and chemoreflex activation on pulmonary artery pressure in chronic heart failure 320
The calculation of the cardiac troponin T 99th percentile of the reference population is affected by age, gender, and population selection: A multicenter study in Italy. 319
Targeting Mitochondrial Dysfunction in Chronic Heart Failure: Current Evidence and Potential Approaches 319
Adrenergic activation in heart failure: blockade or rebalance? 316
Cardiovascular risk factors and gamma-glutamyltransferase fractions in healthy individuals. 313
Amyloid deposits and fibrosis on left ventricular endomyocardial biopsy correlate with extracellular volume in cardiac amyloidosis 311
Abnormal ventricular repolarization in hypertensive patients: role of sympatho-vagal imbalance and left ventricular hypertrophy 310
N-terminal prob-type natriuretic peptide is a marker of vascular remodelling and subclinical atherosclerosis in asymptomatic hypertensives 310
After the SERVE-HF Trial, Is There Still a Need for Treatment of Central Apnea? 308
Galectin-3 and myocardial fibrosis in nonischemic dilated cardiomyopathy 308
Eligibility for vericiguat in a real‐world, contemporary heart failure population 307
Biomarcatori di stabilità della placca aterosclerotica (Rassegna) 307
Clinical and prognostic significance of central and obstructive apnoeas in patients with transthyretin cardiac amyloidosis 306
Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study 306
Prognostic Value of Soluble Suppression of Tumorigenicity-2 in Chronic Heart Failure: A Meta-Analysis 306
Evaluation of analytical performance and comparison of clinical results of the new generation method AccuTnI+3 for the measurement of cardiac troponin I using both patients and quality control plasma samples 306
Sex Profile and Risk Assessment With Cardiopulmonary Exercise Testing in Heart Failure: Propensity Score Matching for Sex Selection Bias 305
Prognostic Value of High-Sensitivity Troponin T in Chronic Heart Failure: An Individual Patient Data Meta-Analysis 304
Using co-creation to develop a cardiology online open course: an effective approach for implementing digital learning 303
Acute right-sided transcutaneous vagus nerve stimulation improves cardio-vagal baroreflex gain in patients with chronic heart failure 303
Glycosylated haemoglobin is associated with neurohormonal activation and poor outcome in chronic heart failure patients with mild left ventricular systolic dysfunction 303
Valutazione delle caratteristiche analitiche di un nuovo metodo di dosaggio del BNP 302
Admission high-sensitivity troponin T and NT-proBNP for outcome prediction in acute heart failure 300
Influence of preload and afterload on stroke volume response to low-dose dobutamine stress in patients with non-ischemic heart failure: A cardiac MR study 300
Sympathetic and Vagal Nerve Activity in COPD: Pathophysiology, Presumed Determinants and Underappreciated Therapeutic Potential 299
An analysis of fMRI signal during voluntary breath hold and carbon dioxide challenge: physiological correction and modeling issues 299
Late gadolinium enhancement as a predictor of functional recovery, need for defibrillator implantation and prognosis in non-ischemic dilated cardiomyopathy 297
Late gadolinium enhancement as a predictor of functional recovery, need for defibrillator implantation and prognosis in non-ischemic dilated cardiomyopathy 297
Screening the health status of people working in a university 296
Acute and persistent effects of a 46-kilometer wilderness trail run at altitude: cardiovascular autonomic modulation and baroreflexes. 296
Evaluation of analytical performance of a novel immunoenzymometric assay for cTnI. 296
AEROBIC TRAINING DECREASES AORTIC STIFFNESS IN PATIENTS WITH HEART FAILURE 295
Echocardiography-Derived Forward Left Ventricular Output Improves Risk Prediction in Systolic Heart Failure 293
Bioinformatics analysis of the gene profile of coronary endothelial cells treated with Grapevine microRNAs: an in vitro study 292
Prognostic role of β-blocker selectivity and dosage regimens in heart failure patients. Insights from the MECKI score database 292
Metabolic exercise data combined with cardiac and kidney indexes: MECKI score. Predictive role in cardiopulmonary exercise testing with low respiratory exchange ratio in heart failure 291
A prognostically meaningful definition of non-dilated left ventricular cardiomyopathy 291
A matter of sex—persistent predictive value of MECKI score prognostic power in men and women with heart failure and reduced ejection fraction: a multicenter study 290
Renal denervation in resistant arterial hypertension: Effects on neurohormonal activation and cardiac natriuretic peptides 290
Meta-Analysis of Soluble Suppression of Tumorigenicity-2 and Prognosis in Acute Heart Failure 289
How to take arms against central apneas in heart failure 289
Usefulness of high-sensitive troponin elevation after effort stress to unveil vulnerable myocardium in patients with hart failure 289
Cardiac biomarker testing in the clinical laboratory:Where do we stand? General overview of the methodology with special emphasis on natriuretic peptides. 287
Natriuretic peptides as biomarkers of cardiac endocrine function in heart failure: New challenges and perspectives 286
Cheyne-Stokes respiration related oscillations in cardiopulmonary hemodynamics in patients with heart failure 285
Sex-related differences in chronic heart failure 284
Effects of central apneas on sympathovagal balance and hemodynamics at night: impact of underlying systolic heart failure 282
Totale 36.517
Salva come PNG Salva come JPEG
Categoria #
all - tutte 601.970
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 601.970
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20226.450 0 1.282 379 663 153 119 764 1.269 561 670 114 476
2022/20235.337 402 312 276 790 779 826 53 432 917 106 244 200
2023/20243.247 292 112 528 227 210 337 303 190 191 167 168 522
2024/202521.093 192 234 1.198 489 999 1.286 2.826 5.165 1.700 1.412 3.316 2.276
2025/202651.227 2.676 8.082 5.678 6.166 5.331 3.021 5.769 2.122 2.720 3.260 3.163 3.239
2026/20272.754 1.328 1.426 0 0 0 0 0 0 0 0 0 0
Totale 120.791